Key Points
Barington Companies Management initiated a 13,000-share position in Chemed during the fourth quarter.
The estimated trade value was $5.56 million.
The position represents 3.65% of 13F reportable assets under management as of December 31, 2025.
On February 12, 2026, Barington Companies Management disclosed a new position in Chemed(NYSE:CHE), acquiring 13,000 shares in an estimated $5.56 million trade.
What happened
According to an SEC filing dated February 12, 2026, Barington Companies Management established a new position in Chemed, acquiring 13,000 shares. The quarter-end value of the stake was $5.56 million.
What else to know
- This new position accounts for 3.65% of Barington Companies Management’s reportable U.S. equity assets following the filing.
- Top five holdings after the filing:
- NYSE: M: $28.66 million (18.8% of AUM)
- NASDAQ: MATW: $26.12 million (17.1% of AUM)
- NYSE: VSCO: $23.02 million (15.1% of AUM)
- NYSE: BILL: $21.27 million (14.0% of AUM)
- NYSE: GIL: $15.94 million (10.5% of AUM)
- As of February 12, 2026, shares of Chemed were priced at $463.95, down 15.18% over the prior year and trailing the S&P 500 by 28.09 percentage points.
Company overview
| Metric | Value |
|---|---|
| Price (as of market close February 12, 2026) | $463.95 |
| Market capitalization | $6.76 billion |
| Revenue (TTM) | $2.53 billion |
| Net income (TTM) | $278.81 million |
Company snapshot
- Chemed operates through two main segments: VITAS, which provides hospice and palliative care services, and Roto-Rooter, offering plumbing, drain cleaning, and water restoration services.
- The company generates revenue primarily from healthcare services delivered to patients and from residential and commercial plumbing and maintenance solutions.
- Its primary customers include patients and families in need of end-of-life care, as well as residential and commercial property owners requiring plumbing and related services.
Chemed is a diversified services company with a strong presence in both the healthcare and essential home services markets. Its dual-segment model enables stable revenue streams by serving critical needs in hospice care and property maintenance. The company leverages its national network, brand strength, and operational expertise to maintain a competitive position in its core markets.
What this transaction means for investors
This move matters because it signals conviction in a steady, cash-rich operator that just hit a rough patch in sentiment, but not in solvency. Chemed generated $624.9 million in third-quarter revenue, up 3.1% year over year, but adjusted diluted EPS came in at $5.27, down 6.6% year over year. GAAP EPS was harder-hit, falling 10.8% to $4.46, but that decline came alongside continued revenue growth at VITAS and Roto-Rooter and ongoing share repurchases.
VITAS revenue climbed 4.2% to $407.7 million, with admissions up 5.6% and average daily census up 2.5%. Roto-Rooter grew revenue 1.1% to $217.2 million, though margins compressed. Importantly, Chemed ended the quarter with $129.8 million in cash and no current or long-term debt, and it reiterated full-year guidance of $22.00 to $22.30 per share.
Within a portfolio dominated by consumer and technology names like Macy’s, Victoria’s Secret, and BILL, this 3.65% position adds defensive exposure in the very different fields of hospice care and essential plumbing services. Ultimately, long-term investors should focus on cash generation, balance sheet strength, and demographic tailwinds in hospice, not a single quarter’s margin pressure.
Should you buy stock in Chemed right now?
Before you buy stock in Chemed, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Chemed wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $414,554!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,120,663!*
Now, it’s worth noting Stock Advisor’s total average return is 884% — a market-crushing outperformance compared to 193% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
*Stock Advisor returns as of February 16, 2026.
Jonathan Ponciano has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Bill Holdings. The Motley Fool has a disclosure policy.
